Jyoti Mayadev1, Lihong Qi2, Susan Lentz3, Stanley Benedict3, Jean Courquin3, Sonja Dieterich3, Mathew Mathai3, Robin Stern3, Richard Valicenti3. 1. Department of Radiation Oncology, University of California Davis Medical Center, Sacramento, CA. Electronic address: jyoti.mayadev@ucdmc.ucdavis.edu. 2. Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of California Davis, Davis, CA. 3. Department of Radiation Oncology, University of California Davis Medical Center, Sacramento, CA.
Abstract
PURPOSE: This investigation details the time and teamwork required for CT-guided tandem and ring high-dose-rate brachytherapy. METHODS AND MATERIALS: From 2010 to 2012, 217 consecutive implantations were identified on 52 patients. We gathered key workflow times: preoperative, applicator insertion, CT image, treatment planning, treatment, patient recovery, and total time in clinic. Linear fixed-effects models were used, and key workflow times were the outcome variables and factors including age, body mass index, stage, outside referral, number of implant per patient, number of implants per day, and year of implantation were examined as fixed effects. RESULTS: Of the 52 patients, 62% of the patients were Fédération Internationale de Gynécologie et d'Obstétrique Stage 2B, 88% were treated with concurrent chemotherapy, and 23% were treated at an outside facility and referred for the procedure. The mean times (minutes) for each step were as follows: preoperative evaluation, 93; insertion, 23; imaging, 45; treatment planning, 137; treatment, removal, and recovery, 115; total clinic time, 401. For the insertion time, the greater implant number per patient was significantly associated with a decreased total insertion time, with and without adjusting for other covariates, p = 0.002 and p = 0.0005, respectively. Treatment planning time was expedited with increasing number of implant per patient and comparing treatment times in 2012 with those in 2010, p = 0.01 and p < 0.0001, respectively. CONCLUSIONS: Gynecologic brachytherapy requires a skillfully coordinated and efficient team approach. Identifying critical components and the time required for each step in the process is needed to improve the safety and efficiency of brachytherapy. Continuous efforts should be made to enhance the optimal treatment delivery in high-dose-rate gynecologic brachytherapy. Published by Elsevier Inc.
PURPOSE: This investigation details the time and teamwork required for CT-guided tandem and ring high-dose-rate brachytherapy. METHODS AND MATERIALS: From 2010 to 2012, 217 consecutive implantations were identified on 52 patients. We gathered key workflow times: preoperative, applicator insertion, CT image, treatment planning, treatment, patient recovery, and total time in clinic. Linear fixed-effects models were used, and key workflow times were the outcome variables and factors including age, body mass index, stage, outside referral, number of implant per patient, number of implants per day, and year of implantation were examined as fixed effects. RESULTS: Of the 52 patients, 62% of the patients were Fédération Internationale de Gynécologie et d'Obstétrique Stage 2B, 88% were treated with concurrent chemotherapy, and 23% were treated at an outside facility and referred for the procedure. The mean times (minutes) for each step were as follows: preoperative evaluation, 93; insertion, 23; imaging, 45; treatment planning, 137; treatment, removal, and recovery, 115; total clinic time, 401. For the insertion time, the greater implant number per patient was significantly associated with a decreased total insertion time, with and without adjusting for other covariates, p = 0.002 and p = 0.0005, respectively. Treatment planning time was expedited with increasing number of implant per patient and comparing treatment times in 2012 with those in 2010, p = 0.01 and p < 0.0001, respectively. CONCLUSIONS: Gynecologic brachytherapy requires a skillfully coordinated and efficient team approach. Identifying critical components and the time required for each step in the process is needed to improve the safety and efficiency of brachytherapy. Continuous efforts should be made to enhance the optimal treatment delivery in high-dose-rate gynecologic brachytherapy. Published by Elsevier Inc.
Authors: Antonio L Damato; Larissa J Lee; Mandar S Bhagwat; Ivan Buzurovic; Robert A Cormack; Susan Finucane; Jorgen L Hansen; Desmond A O'Farrell; Alecia Offiong; Una Randall; Scott Friesen; Akila N Viswanathan Journal: Brachytherapy Date: 2015-01-06 Impact factor: 2.362
Authors: Corinne McDaniels-Davidson; Christine H Feng; Maria Elena Martinez; Alison J Canchola; Scarlett Lin Gomez; Jesse N Nodora; Sandip P Patel; Arno J Mundt; Jyoti S Mayadev Journal: Cancer Date: 2022-08-02 Impact factor: 6.921
Authors: Yesenia Gonzalez; Chenyang Shen; Hyunuk Jung; Dan Nguyen; Steve B Jiang; Kevin Albuquerque; Xun Jia Journal: Med Image Anal Date: 2020-12-16 Impact factor: 8.545